Anti-GRP78 antibodies were used for targeting cell surface-associated GRP78 in hepatocellular carcinoma cells (Mahlavu and SMMC7721 cell lines); such antibody-conferred neutralization of the endogenous cell surface chaperone led to the inhibition of cell adhesion and invasion [243]. Here, HSPA5 is linked to hepatocellular carcinoma.